Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene

NCT01072318 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

495

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole

Sponsor

Korean Breast Cancer Study Group